Brief: BRAIN Resolves On Cash Capital Increase

BRAIN Biotech AG

04/06/2020 06:38

June 4 (Reuters) - BRAIN BIOTECHNOLOGY RESEARCH AND
INFORMATION NETWORK AG  BNNn.DE :
    * RESOLVES ON A CASH CAPITAL INCREASE FROM AUTHORISED
CAPITAL
    * TO INCREASE CO'S SHARE CAPITAL AGAINST CASH CONTRIBUTION
BY
ISSUING NEW REGISTERED SHARES WITH NO PAR VALUE WITH TARGETED
PROCEEDS OF ABOUT EUR 13 MILLION
    * EACH SUCH SHARE HAS NOTIONAL VALUE OF EUR 1.00 OF
COMPANY'S
SHARE CAPITAL
    * NEW SHARES WILL CARRY FULL DIVIDEND RIGHTS FOR FISCAL YEAR
2019/2020 BEGINNING ON OCTOBER 1, 2019
    * TO USE NET PROCEEDS TO INCREASE EFFICIENCY OF CO'S
PRODUCTION
PROCESS IN ENZYMES AREA, ACCELERATE R&D FOR PRODUCT DEVELOPMENT,
FOR OPPORTUNISTIC BOLT-ON ACQUISITIONS, FOR BUY-OUT OF CERTAIN
MINORITY SHAREHOLDERS IN CO'S SUBSIDIARIES; GENERAL CORPORATE
PURPOSES
    * BRAIN'S MAIN SHAREHOLDER HAS ALSO ANNOUNCED ITS INTENTION
TO
PARTICIPATE IN CAPITAL INCREASE
    * FINAL OFFER PRICE OF NEW SHARES WILL BE ANNOUNCED UPON
COMPLETION OF THE BOOKBUILDING PROCESS EXPECTED TO BE ON 4 JUNE
2020
    * NEW SHARES ARE EXPECTED TO BE ADMITTED TO TRADING WITHOUT
PROSPECTUS ON 9 JUNE 2020

Source text for Eikon:  ID:nEQ7f9qrta 
Further company coverage:  BNNn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))